Who is Archimed?

ArchiMed was established in March 2014 by Denis Ribon and Vincent Guillaumot and is headquartered in Lyon with a focus on healthcare

What does Archimed do?

ArchiMed was established in March 2014 by Denis Ribon and Vincent Guillaumot and is headquartered in Lyon. Observing trends in the US, Ribon and Guillaumot left 3i / Cerba to start ArchiMed with the specific objective of becoming the leading healthcare specialist in Europe. The team has grown substantially over the past few years and now consists of 45 investment professionals as well as a “MedTalent Network” of >250 healthcare executives attempting to build a “one-stop shop for small and mid-cap healthcare private equity”.

Some companies Archimed has invested in

Polyplus

NAMSA

Carso

Why do we back Archimed?

“ArchiMed offers the opportunity to invest in a leading European dedicated healthcare specialist that has unparalleled operational expertise, particularly in the small and mid-cap market. Over the past few years of tracking ArchiMed, we have seen them evolve through strong hires and interesting deal execution. This expertise has been confirmed through abrdn's experience of working on the Polyplus transaction as well as other co-investment opportunities.” – Alistair Watson, Senior Investment Director, abrdn.

Region

Western Europe and North America

Core Sectors

Dedicated healthcare specialist. 6 target sub-sectors: MedTech, Biopharma, Life Sciences, Diagnostics, Consumer Health and Healthcare IT

Target Company Size

EV Range - €150m- 750m

Investment Strategy

Recognised healthcare sector specialist with combined PE and extensive operational experience. Heavy buy-and-build focus

Risk warning
Risk warning
The value of investments and the income from them can go down as well as up and you may get back less than the amount invested. Please refer to the relevant Key Information Document (KID) prior to making an investment decision. Please be aware of scams that can affect investors.